MOLNMOLECULAR PARTNERS AG

Nasdaq molecularpartners.com


$ 6.02 $ 0.16 (2.66 %)    

Monday, 05-Aug-2024 15:58:02 EDT
QQQ $ 445.48 $ -0.10 (-0.02 %)
DIA $ 389.72 $ 3.15 (0.81 %)
SPY $ 528.04 $ 0.25 (0.05 %)
TLT $ 96.88 $ -2.21 (-2.24 %)
GLD $ 220.73 $ -1.78 (-0.8 %)
$ 6.17
$ 5.90 x 200
-- x --
-- - --
$ 3.32 - $ 12.70
2,023
na
224.31M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for June 14th
06/14/2024 12:34:25

ADBE: 16% | Adobe shares are trading higher following better-than-expected Q2 earnings and strong guidance. BPTH: 46% | Bio-Pa...

 molecular-partners-reveals-preclinical-data-for-first-switch-darpin-candidate-mp0621-at-eha-2024

Proof-of-concept of Switch-DARPin platform established in vivo, enabling the use of logic-gated and reversible immune activat...

Core News & Articles
Market-Moving News for June 11th
06/11/2024 12:29:09

MOLN: 11% | Molecular Partners shares are trading higher after the company announced the debut of their lead Raido-DARPin thera...

 reported-saturday-molecular-partners-presented-data-from-completed-phase-1-trial-of-mp0317-monotherapy-in-advanced-solid-tumors-at-asco-2024

Mechanism of action supported by observed MP0317 localization and immune cell activation in the tumor microenvironment Favor...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION